n-(2-chloroethyl)-n-nitrosoacetamide has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joshua, AV; Lown, JW; McLaughlin, LW | 1 |
| Finch, RA; Penketh, PG; Sartorelli, AC; Shyam, K | 1 |
| Barascut, JL; Bourut, C; Carminati, A; Chenut, E; Imbach, JL; Mathé, G | 1 |
3 other study(ies) available for n-(2-chloroethyl)-n-nitrosoacetamide and Leukemia L 1210
| Article | Year |
|---|---|
Noval antitumor nitrosoureas and related compounds and their reactions with DNA.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Cross-Linking Reagents; DNA; Leukemia L1210; Mice; Nitrosourea Compounds; Structure-Activity Relationship | 1980 |
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
Topics: Animals; Antineoplastic Agents; Carmustine; Drug Screening Assays, Antitumor; Female; Humans; Hydrazines; Leukemia L1210; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Nitroso Compounds; Prodrugs; Xenograft Model Antitumor Assays | 2001 |
On a new class of mixed-function drugs associating nitroimidazoles and CENU: the NICE-NU.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry, Physical; Leukemia L1210; Melanoma, Experimental; Mice; Nitroimidazoles; Nitroso Compounds; Structure-Activity Relationship | 1988 |